Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Hypromellose Phthalate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 8DULOXETINE HYDROCHLORIDE

    02 3OMEPRAZOLE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ACTAVIS ELIZABETH

    DULOXETINE HYDROCHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    ACTAVIS ELIZABETH
    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DULOXETINE HYDROCHLORIDE

    Drug : DULOXETINE HYDROCHLORIDE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 90776

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACTAVIS LABS FL INC

    OMEPRAZOLE

    arrow
    2024 ACI Convention
    Not Confirmed
    ACTAVIS LABS FL INC
    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OMEPRAZOLE

    Drug : OMEPRAZOLE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 75347

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ALEMBIC

    DULOXETINE HYDROCHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    ALEMBIC
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DULOXETINE HYDROCHLORIDE

    Drug : DULOXETINE HYDROCHLORIDE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 202949

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    GLENMARK PHARMS LTD

    OMEPRAZOLE

    arrow
    2024 ACI Convention
    Not Confirmed
    GLENMARK PHARMS LTD
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OMEPRAZOLE

    Drug : OMEPRAZOLE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 91672

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    INVENTIA

    DULOXETINE HYDROCHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    INVENTIA
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DULOXETINE HYDROCHLORIDE

    Drug : DULOXETINE HYDROCHLORIDE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 202336

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    LUPIN LTD

    DULOXETINE HYDROCHLORIDE

    arrow
    PackExpo
    Not Confirmed
    LUPIN LTD
    India
    arrow
    PackExpo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DULOXETINE HYDROCHLORIDE

    Drug : DULOXETINE HYDROCHLORIDE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 90694

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    MARKSANS PHARMA

    DULOXETINE HYDROCHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    MARKSANS PHARMA
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DULOXETINE HYDROCHLORIDE

    Drug : DULOXETINE HYDROCHLORIDE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 90723

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    SANDOZ

    OMEPRAZOLE

    arrow
    2024 ACI Convention
    Not Confirmed
    SANDOZ
    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OMEPRAZOLE

    Drug : OMEPRAZOLE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 75757

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    ZYDUS HLTHCARE

    DULOXETINE HYDROCHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    ZYDUS HLTHCARE
    India
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DULOXETINE HYDROCHLORIDE

    Drug : DULOXETINE HYDROCHLORIDE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 90739

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    ZYDUS PHARMS

    DULOXETINE HYDROCHLORIDE

    arrow
    2024 ACI Convention
    Not Confirmed
    ZYDUS PHARMS
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DULOXETINE HYDROCHLORIDE

    Drug : DULOXETINE HYDROCHLORIDE

    Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL

    Application Number : 90728

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF